Letters In Drug Design & Discovery

Journal Title：Letters In Drug Design & Discovery

Aims & Scope

Letters in Drug Design & Discovery publishes letters, mini-reviews, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of latest Internet technology for both submission and review of manuscripts. The online journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

目标与范围

《药物设计与发现快报》发表信函、小评论、亮点和客座编辑的专题，涉及合理药物设计和发现的所有领域，包括药物化学、计算机药物设计、组合化学、高通量筛选、药物靶标和结构-活性关系。重点是通过充分利用最新的互联网技术提交和审查稿件，以非常快的速度发表高质量的论文。对于所有参与药物设计和发现研究的制药科学家来说，这本在线期刊都是必读之作。

Letters In Drug Design & Discovery创刊于2004年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵盖医学 - 医药化学全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度 约3.0个月 ，影响因子指数1.2，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。